BMRN Financial Facts
Weighted average common shares outstanding, diluted: 112.29MSelling, general and administrative: 44.88M
See Full Income Statement
Property, plant and equipment, net: 266.19M
Goodwill: 51.54M
See Full Balance Sheet
BioMarin Pharmaceutical Inc. (BMRN) Earnings
|
Expand Research on BMRN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +112.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/27/22 | Q222 | N/A | $0.01 | N/A | N/A | $522.56M | N/A | N/A | N/A | ||
| 4/27/22 |  |
Q122 | $0.63 | $0.17 | +$0.46 | $519M | $507.52M | N/A |  | | Details |
| 2/23/22 | |
Q421 | -$0.32 | -$0.32 | $0.00 | $449.8M | $442.09M | N/A | | | Details |
| 10/27/21 | |
Q321 | -$0.20 | -$0.24 | +$0.04 | $408.7M | $435.89M | N/A | | | Details |
| 7/28/21 | |
Q221 | $0.07 | -$0.11 | +$0.18 | $501.7M | $448.79M | N/A | | | Details |
| 4/29/21 | |
Q121 | $0.09 | -$0.10 | +$0.19 | $486M | $446.45M | N/A | | | Details |
| 2/25/21 | |
Q420 | $0.12 | -$0.19 | +$0.31 | $452.1M | $440.23M | N/A | | | Details |
| 11/5/20 | |
Q320 | $4.01 | $1.29 | +$2.72 | $476.8M | $454.64M | N/A | | | Details |
